Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma.

MLA

Ravanetti, Lara, et al. “Efficacy of FP-025: A Novel Matrix Metalloproteinase-12 (MMP-12) Inhibitor in Murine Allergic Asthma.” Allergy, vol. 78, no. 2, Feb. 2023, pp. 559–62. EBSCOhost, https://doi.org/10.1111/all.15513.

APA

Ravanetti, L., Dekker, T., Guo, L., Dijkhuis, A., Dierdorp, B. S., Diamant, Z., Florquin, S., & Lutter, R. (2023). Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma. Allergy, 78(2), 559–562. https://doi.org/10.1111/all.15513

Chicago

Ravanetti, Lara, Tamara Dekker, Lihui Guo, Annemiek Dijkhuis, Barbara S Dierdorp, Zuzana Diamant, Sandrine Florquin, and René Lutter. 2023. “Efficacy of FP-025: A Novel Matrix Metalloproteinase-12 (MMP-12) Inhibitor in Murine Allergic Asthma.” Allergy 78 (2): 559–62. doi:10.1111/all.15513.